Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doravirine Concentrations in Genital Fluids
NCT04097925Phase 2Completed
- Start
- Feb 2020
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of doravirine in human immunodeficiency virus type 1 infection (HIV-1). Started Feb 2020; status: completed.
02
Drugs
doravirine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT04097925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04097925.